Literature DB >> 188540

Adriamycin cardiotoxicity in children: case reports, literature review, and risk factors.

M N Prout, M J Richards, K J Chung, P Joo, H L Davis.   

Abstract

Two children with Wilms' tumor and prior thoracic radiation developed congestive heart failure at cumulative adriamycin doses of 350 mg/m2 and 400 mg/m2. Details of these two cases and a summary of previously reported adriamycin cardiotoxicity in children are presented. Dose recommendations and predictive tests are discussed.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 188540     DOI： 10.1002/1097-0142(197701)39:1<62::aid-cncr2820390112>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  5 in total

1.  Possible enhancement of the cardiotoxicity of doxorubicin when combined with mitomycin C.

Authors:  F Villani; R Comazzi; G Lacaita; A Guindani; V Genitoni; A Volonterio; M C Brambilla
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

Review 2.  Doxorubicin-Induced Cardiomyopathy in Children.

Authors:  Trevi R Mancilla; Brian Iskra; Gregory J Aune
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

3.  Fluorouracil cardiotoxicity.

Authors:  D P Mikhailidis; D S Gillett; D Lang-Stevenson
Journal:  Br Med J       Date:  1978-04-29

4.  Assessment of adriamycin cardiotoxicity in children by systolic time intervals.

Authors:  H E Ulmer; R Ludwig; H Geiger
Journal:  Eur J Pediatr       Date:  1979-04-25       Impact factor: 3.183

5.  Cardiac function in long-term survivors of childhood lymphoma.

Authors:  Mark K Friedberg; Ido Solt; Myriam Weyl-Ben-Arush; Yulia Braver; Avraham Lorber
Journal:  Cardiol Res Pract       Date:  2011-01-20       Impact factor: 1.866
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.